Encinitas, CA, United States of America

Gary R Eldridge

This inventor holds 17 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Sequoia Sciences, Inc., Sequoia Vaccines, Inc.. Active years: 2008-2021.

USPTO Granted Patents = 17 

% Patents Active = 82.4

 

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 106(Granted Patents)


Location History:

  • San Diego, CA (US) (2008)
  • Encinitas, CA (US) (2009)
  • St. Louis, MO (US) (2009 - 2021)

Company Filing History:


Years Active: 2008-2021

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Gary R Eldridge - Pioneering Inventor from Encinitas, CA

Introduction: Gary R Eldridge is a renowned inventor hailing from Encinitas, California. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology.

Latest Patents: Gary R Eldridge holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to existing challenges.

Career Highlights: Throughout his illustrious career, Gary R Eldridge has been instrumental in developing groundbreaking technologies that have revolutionized industries. His innovative spirit and dedication to excellence have earned him a reputation as a trailblazer in the field of invention.

Collaborations: Gary R Eldridge has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of cutting-edge technologies.

Conclusion: In conclusion, Gary R Eldridge's remarkable contributions to the world of innovation have left an indelible mark on the technological landscape. His inventive prowess and commitment to pushing the boundaries of what is possible continue to inspire future generations of inventors.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…